These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21323131)

  • 1. Cognitive deficits presenting as psychiatric symptoms in a patient with Moyamoya disease.
    Zalonis I; Christidi F; Kararizou E; Triantafyllou NI; Spengos K; Vassilopoulos D
    Psychol Rep; 2010 Dec; 107(3):727-32. PubMed ID: 21323131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different aspects of dysexecutive syndrome in patients with moyamoya disease and its clinical subtypes.
    Fang L; Huang J; Zhang Q; Chan RC; Wang R; Wan W
    J Neurosurg; 2016 Aug; 125(2):299-307. PubMed ID: 26722860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive function of patients with adult moyamoya disease.
    Araki Y; Takagi Y; Ueda K; Ubukata S; Ishida J; Funaki T; Kikuchi T; Takahashi JC; Murai T; Miyamoto S
    J Stroke Cerebrovasc Dis; 2014 Aug; 23(7):1789-94. PubMed ID: 24957308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olfactory deficits and cognitive dysfunction in Parkinson's disease.
    Parrao T; Chana P; Venegas P; Behrens MI; Aylwin ML
    Neurodegener Dis; 2012; 10(1-4):179-82. PubMed ID: 22343138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moyamoya disease: a review of the literature.
    Hertza J; Loughan A; Perna R; Davis AS; Segraves K; Tiberi NL
    Appl Neuropsychol Adult; 2014; 21(1):21-7. PubMed ID: 24826492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single case report of Moyamoya disease presenting in a psychiatric setting.
    Schwarz LR; Thurstin AH; Levine LA
    Appl Neuropsychol; 2010 Jan; 17(1):73-7. PubMed ID: 20146125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of moyamoya disease on neuropsychological functioning in adults.
    Karzmark P; Zeifert PD; Tan S; Dorfman LJ; Bell-Stephens TE; Steinberg GK
    Neurosurgery; 2008 May; 62(5):1048-51; discussion 1051-2. PubMed ID: 18580802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different aspects of cognitive function in adult patients with moyamoya disease and its clinical subtypes.
    Shi Z; Wen YJ; Huang Z; Yu LB; Zhang D
    Stroke Vasc Neurol; 2020; 5(1):86-96. PubMed ID: 32411413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive functions in juvenile and adult patients with gelastic epilepsy due to hypothalamic hamartoma.
    Quiske A; Frings L; Wagner K; Unterrainer J; Schulze-Bonhage A
    Epilepsia; 2006 Jan; 47(1):153-8. PubMed ID: 16417543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Executive function and diffusion in frontal white matter of adults with moyamoya disease.
    Nakamizo A; Kikkawa Y; Hiwatashi A; Matsushima T; Sasaki T
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):457-61. PubMed ID: 23608368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuropsychological evaluation and psychopathology of multiple sclerosis].
    Defer G
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1128-34. PubMed ID: 11787345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of psychiatric co-morbidity on cognitive functioning in a population-based sample of depressed young adults.
    Castaneda AE; Marttunen M; Suvisaari J; Perälä J; Saarni SI; Aalto-Setälä T; Aro H; Lönnqvist J; Tuulio-Henriksson A
    Psychol Med; 2010 Jan; 40(1):29-39. PubMed ID: 19413917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of cognitive impairment in bipolar disorder.
    Torrent C; Martinez-Arán A; del Mar Bonnin C; Reinares M; Daban C; Solé B; Rosa AR; Tabarés-Seisdedos R; Popovic D; Salamero M; Vieta E
    J Clin Psychiatry; 2012 Jul; 73(7):e899-905. PubMed ID: 22901360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult with Middle Interhemispheric Variant of Holoprosencephaly: Neuropsychological, Clinical, and Radiological Findings.
    Virta M; Launes J; Valanne L; Hokkanen L
    Arch Clin Neuropsychol; 2016 Aug; 31(5):472-9. PubMed ID: 27235161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity and reliability of the Behavioural Assessment Tool for Cognition and Higher Function (BATCH) in neuropsychiatric patients.
    Miller K; Walterfang M; Randhawa S; Scholes A; Mocellin R; Velakoulis D
    Aust N Z J Psychiatry; 2007 Aug; 41(8):697-704. PubMed ID: 17620167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple system atrophy with early cognitive deficits: a case report.
    Spaccavento S; Del Prete M; Loverre A; Craca A; Nardulli R
    Neurocase; 2013; 19(6):613-22. PubMed ID: 22978465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia.
    Malhi GS; Ivanovski B; Hadzi-Pavlovic D; Mitchell PB; Vieta E; Sachdev P
    Bipolar Disord; 2007; 9(1-2):114-25. PubMed ID: 17391355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive deficits in chronic fatigue syndrome and their relationship to psychological status, symptomatology, and everyday functioning.
    Cockshell SJ; Mathias JL
    Neuropsychology; 2013 Mar; 27(2):230-42. PubMed ID: 23527651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.